Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Biosciences, Affinity Collaborate on Assay Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Predictive Biosciences and Affinity Life Sciences today said they are collaborating to develop biomarker assays for use in clinical studies.

Financial and other terms of the deal were not disclosed.

In a statement, Predictive Bio, based in Lexington, Ky., said the collaboration provides it with access to Affinity's expertise in biomarker immunoassay development. It added that with Affinity's support it will expand its cancer diagnostic menu.

Predictive develops molecular diagnostic cancer assays and provides anatomic pathology laboratory solutions. Affinity is a contract research organization based in Milford, NH, specializing in biomarker and immunochemistry assay development for research use or under cGMP conditions.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.